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Characterization of Rat Hepatic Acetyltransferase
Susan J. Land and Charles M. King
Department of Chemical Carcinogenesis, Michigan Cancer Foundation, Detroit, Michigan
Rat liver cytosol is capable of N-acetylation (NAT) of arylamines, O-acetylation (OAT) of arylhydroxylamines, and NO-acetyltransfer (AHAT) of arylhy-
droxamic acids. Physical, enzymatic, and immunochemical techniques now support the conclusion that a single 32 kDa protein accounts for all of
these activities. Of the five immunoglobulin (lgG1) mouse monoclonal antibodies (mAb) produced against this protein, each affected one or more of
these acetylation activities. When mixed with rat hepatic cytosol and then chromatographed on a gel filtration column, mAbs 1 F2 and 5F8 increased
the apparent size of all enzymes capable of acetylation from 32 kDa to the exclusion volume. Each of the mAbs reacted with only a single 32 kDa
protein on SDS-PAGE/VVestern blots, regardless of the state of purity of the enzyme. This enzyme is unstable in low salt solutions, as reflected by a
relative loss in NAT versus AHAT activity, but it does not result in changes in either molecular weight or isoelectric point (pl). A second form of insta-
bility is shown by the formation of more basic peptides with pls as high as 6, again without change in molecular weight. Although NAT activity is
retained in acetyltransferase (AT) that has a minimally modified pl, further increases in pl result in total loss of enzyme activity. The differential
effects of the mAbs on AT suggest that the ratios of NAT, OAT, and AHAT may be highly dependent on the conformation of the enzyme and, con-
sequently, provide insight as to why the abilities of ATs from different species exhibit such dissimilar potentials for the activation of aromatic amines
by OAT and AHAT. - Environ Health Perspect 102(Suppl 6):91-93 (1994)
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Introduction
Exposure to aromatic amines comes from
occupational, environmental, dietary, and
pharmacologic sources. Experimentally,
these compounds have been shown to have
a multiplicity of carcinogenic, mutagenic,
or toxic effects in a variety of biologic sys-
tems (1). Metabolic activation of these
compounds involves N-oxidation followed
by conjugation to form O-esterified
hydroxylamines that can react with DNA
(2). Reactive N-acetoxy metabolites can be
formed through the direct O-acetylation
(OAT) ofhydroxylamines by acetyl-S-CoA
(3), or through internal N,O-acetyltransfer
of acetohydroxamic acids (AHAT) (4,5).
These metabolites, which are capable of
altering nucleic acid, are believed to be
involved in the production of mammary and
possibly other tumors by these agents (6).
The objective ofthis study was to estab-
lish the nature ofthe cytosolic enzyme(s) of
rat liver that is capable of N-acetylation
(NAT), OAT, and AHAT. The rat was
selected for study because of the relatively
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greater susceptibilities ofseveral organs of
this species as compared, for example, to the
mouse (1), which may be due to the greater
ability ofthe rat to activate aromatic amines
by formation of N-acetoxyarylamines (7).
The results ofthis study support the conclu-
sion that a single enzyme from rat livercytosol
is capable ofNAT, OAT, and AHAT.
Acetylation Assays
Three types ofassays were used to estimate
acetylation capability: a) estimation of the
N-acetylated product, b) estimation of
DNA adduct formation, and c) loss ofsub-
strate. AHAT, OAT, and NAT assays were
carried out as in Table 1. Except for local-
ization ofacetyltransferase (AT) in column
fractions, all samples were assayed at six to
10 different enzyme concentrations. The
activities were derived from an average of
those concentrations that showed a linear
response.
Effect of Buffer Concentration
on Enzyme Activity
Rat liver was homogenized in varying con-
centrations of sodium pyrophosphate
(NaPPi) buffer (1mM DTT, pH 7.4).
After differential centrifugation, enzyme
assays were carried out in 50 mM NaPPi
buffer. As the buffer concentration was
lowered from 50 to 2 mM, the ratio of2-AF
NAT:AHAT was lowered from 33 to 16.
Assay ofthe acetylation activities following
exposure to techniques that employed low
buffer concentrations (e.g., DEAE ion
exchange chromatography in 2 mM NaPPi),
showed a similar change in the ratio of 2-
AF NAT:AHAT. The ratios ofAHAT:
OAT:Booth:SMZNAT (1:3:0.05:30) were
unaltered as was the ratio of 2-AF
NAT:PABA NAT (1.5:1).
Enzyme Characterization
Using Monclonal Antibodies
Five monoclonal (mAbs) were produced
using a partially purified rat hepatic AT as
an antigen. To assess their effects on AT
activities, varying quantities of mAbs were
added to enzyme preparations and incu-
bated at 40C under argon for 2 hr. Enzyme
assays were performed using this mixture as
the enzyme preparation. The degree of
inhibition was calculated based on the
decrease of activity compared to that of
control incubations without mAb. Each of
the mAbs was shown to affect one or more
of the acetylation reactions. The mAbs fell
into three groups: 1A3 inhibited all three
acetylation reactions, 1F2 and 5F8 inhib-
ited AHAT and OAT but increased 2-AF
NAT, and 4B4 and 4B5 had no affect on
AHAT or OAT but increased 2-AF NAT
activity. Estimates of the abilities of these
mAbs to complex with acetylases present in
liver cytosol were obtained by mixing the
mAbs with rat liver cytosol and then
chromatographing the mixture on a gel fil-
tration column. Experiments with 1F2 and
5F8 led to the elution of all AT activities
from the column with the exclusion vol-
ume (i.e., >70 kDa) instead oftheir charac-
teristic migration as a 32 kDa molecular
weight protein. Thus, both of these mAbs
bound all protein capable of acetylation.
The apparently lower affinities of the 1A3,
4B4, and 4B5 mAbs failed to modify the
elution pattern oftheAT.
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Table 1. Reactions catalyzed by cytosolic rat liver acetyltransferase.
Acetyl donor Acetyl acceptor Reference Reaction Detection
NAT 3H-Acetyl-S-CoA Arylamine N-Acetylation 3H-Acetamide
2-AF (8)
SMZ (9)
PABA (8)
OAT Acetyl-S-CoA Arylhydroxylamine O-Acetylation 3H-Arylamine nucleic acid adduct
(ring labeled) N-OH-DMABP (8)
AHAT Arylhydroxamic acid Arylhydroxylaminea NO-Acetyltransfer, intramoleculartransfer 3H-Arylamine nucleic acid adduct
(ring labeled) N-OH-AAF (ring labeled) N-OH-AF (3,8)
Booth Hydroxamic acid Arylamine N-Acetylation (N,N'-transacetylation) Loss of absorbance with loss of
N-OH-AABP MB (10) arylamine
Abbreviations: NAT, N-acetylation; OAT, 0-acetylation; AHAT, N,O-acetyltransfer; N-OH-AAF, N-hydroxy-N-acetyl-2-aminofluorene; N-OH-AABP, N-hydroxy-N-acetyl-4-
aminobiphenyl; 2-AF, 2-aminofluorene; SMZ, sulfamethazine; PABA, p-aminobenzoic acid; N-OH-DMABP, N-hydroxy-3,2'-dimethyl-4-aminobiphenyl; AAB, 4-aminoazoben-
zene. aFormed by deacetylation ofthe arylhydroxamic acid (N-OH-AAF).
The mAb showing the highest inhibi-
tion (1A3) was covalently linked to protein
A Sepharose for use as an immunoaffinity
absorbent. Application of an AT prepara-
tion, partially purified from cytosol by
sequential ion exchange chromatography
on DEAE and gel filtration chromatogra-
phy, to this column resulted in over 90%
ofthe AHAT activity emerging in the flow-
through fractions (i.e., in 50 mM NaPPi at
pH 7.4 [1 mM DTT-1). SDS-PAGE ofthe
fractions showed that the more slowly
emerging AT was displaced from the other
proteins and was purified to apparent
homogeneity. This protein, which was
immunoreactive on SDS-PAGE, had
AHAT, OAT, NAT, and Booth activities.
A second affinity column was produced
using mAb 1F2. In contrast to the 1A3 col-
umn, the 1F2 column retained all AHAT,
OAT, and NAT activity. Western blot
analysis indicated that while the AT prepa-
ration applied to the column showed immu-
noreactivity, none of the antigen was
detected on elution of the column with
NaPPi buffer. On elution of the column
with diethylamine, pH 11.2, SDS-PAGE
of the eluted fractions showed a single,
immunoreactive band at 32 kDa. Although
this column had a high binding capacity,
the enzyme activity was lost during the
procedure.
The uniqueness ofrat liver AT was fur-
ther supported by the observations that
only a single immunoreactive band at 32
kDa was obtained with each of the 5
mAbs, with preparations obtained sequen-
tially by precipitation of cytosol with
ammonium sulfate, ion-exchange chro-
matography, gel filtration, and both ofthe
immunoaffinity columns described above.
Isoelectric Focusing
The isoelectric point (pI) of the protein
was determined using an LKB Ultraphor.
AT at various stages of purity were elec-
trophoresed on a prefocused Ampholine
polyacrylamide gel, pH 3.5 to 9.5. Western
blot analysis showed a major immunoreac-
tive band at pI 4.5 using an ammonium
sulfate preparation (Figure 1). A minor
band at pI 4.8 was observed inconsistently
upon repetition ofthe procedure. As purifi-
cation proceeded through the steps
described above, additional bandswith higher
pIs were found. In an attempt to associate
activity with pI, IEF in polyacrylamide gel
ofAT purified through gel filtration was
sliced, the protein was eluted, and acetyla-
tion assays were performed. Two bands of
activity were found. The protein at pI 4.5
had AHAT, Booth, OAT, PABA NAT, 2-
AF NAT, and SMZ NAT activities, while
the protein at pl 4.8 had only PABA NAT
and 2-AF NAT activities. SDS-PAGE/
Westerns ofthe eluted proteins showed only
a single immunoreactive band at 32 kDa.
In an attempt to ascertain whether the
enzymatically active component with the
higher isoelectric point was native to rat
liver or whether it had been formed as a
consequence oflaboratory manipulation, a
rat liver preparation maintained in 50 mM
1 2 3 5
Figure 1. Analytical isoelectric focusing (IEF) of acetyltransferase at various stages of purification. IEF was carried
out on IEF-PAGE at 10°C for 2 hr following purification by: lane 1, ammonium sulfate precipitation; lane 2, ion-
exchange chromatography; lane 3, gel filtration; lane 4, 1A3-affinity chromatography; and lane 5, 1F2-affinity chro-
matography. Protein detection was by silver stain. Western blot analysis utilized a mixture of antiacetyltransferase
mAbs. The lanes marked contain isoelectric point standards. The immunoreactive proteins marked a and b corre-
spond to the two peaks of enzyme activity described in the text.
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NaPPi buffer through homogenization,
differential centrifugation, gel filtration,
and concentration by ultrafiltration under
argon was focused in solution for 2 hr on a
BioRad Rotofor in which a prefocused gra-
dient had been established. The pH ofthe
fractions was determined prior to mixing
with an equal volume of 100 mM NaPPi
buffer. Subsequent enzyme assays and
SDS-PAGE/Westerns all showed a single
peak ofactivity at pH 4.8/32 kDa with no
evidence ofheterogeneity.
Protein Analyses
The possibility that the loss ofcarbohydrate
from AT might account for the formation
ofAT derivatives with increased pIs was
examined by treating a partially purified
AT (after DEAE ion exchange chromatog-
raphy) preparation with neuraminidase.
The reaction was followed with AHAT and
2-AF NAT assays and with SDS-
PAGE/Western blot analysis. Neither loss
ofAHAT activity, as compared with 2-AF
NAT activity, nor increases in pI were
observed. AT was also tested for carbohy-
drate using an enzyme immunoassay sys-
tem to detect digoxigenin-labeled glycans
(11). Transferrin was used as a positive
control. To localize AT, a Western blot of
a duplicate gel was developed using a mix-
ture ofmAbs. Rat hepatic AT proved to be
negative for glycan content.
Discussion
Rat liver cytosol is capable ofNAT ofaryl-
amines, OAT ofarylhydroxylamines, and
AHAT of arylhydroxamic acids; the latter
two reactions may be directly involved in
the production of tumors by these agents
(6). Physical, enzymatic, and immuno-
chemical techniques now support the con-
clusion that a single 32 kDa protein is
capable ofall ofthese activities. The ratios
ofacetylation reactions to one another have
been observed to change with low salt, high
salt, and on binding of the various mAbs.
The observed losses in enzymatic activity as
the pl increased cannot be accounted for
by proteolytic degradation because the
molecular weight had not been changed.
The AT was tested and found to be negative
for carbohydrate, thus loss ofan acidic glycan
is not responsible for these differences in pl.
Whether a loss of phosphate or sulfate
groups could account for the higher pI values
has not yet been explored. It is also possible
that the increase in pI and loss of activity
could be due to conformational differences.
The microheterogeniety observed via pl
determinations and differences in acetyla-
tion capabilities appears to be an artifact of
the purification process, although it cannot
be ruled out that there is a family ofsimi-
larly sized and closely related enzymes that
share antigenic sites and are also capable of
these acetylation reactions. Alternative
experimental approaches with molecular
biologic techniques may provide further
insight into this enzyme system that is
believed to play an important role in modi-
fying the carcinogenic effects of the aro-
matic amines.
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